◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksM › MD

Mednax Inc (MD) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL CARE FACILITIES · DATA UPDATED 2026-09-06

Mednax Inc (MD) operates in the MEDICAL CARE FACILITIES industry and is headquartered in Sunrise, United States with about 4,280 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, MD reported $1.9B in revenue and $165M in net income.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

Interactive charts & full statements → Open the MD valuation workbench →

MD Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$2.0B$1.9B$2.0B$2.0B$2.0B$1.9B$1.7B$1.8B$3.6B$3.5B$3.2B$2.8B$2.4B$2.2B$1.8B$1.6B$1.4B$1.3B$1.1B$918M$819M
Gross Profit$506M$472M$454M$422M$467M$513M$449M$503M$990M$1.0B$1.0B$928M$807M$710M$614M$551M$489M$453M$380M$350M$317M
Gross Margin %25.9%24.7%22.6%21.1%23.7%26.9%25.9%28.3%27.1%28.9%32.5%33.4%33.1%33.0%33.8%34.7%34.9%35.1%35.6%38.2%38.7%
Operating Income (EBIT)$226M$231M($69M)$7M$173M$203M$98M$172M$446M$480M$572M$558M$513M$452M$390M$355M$313M$289M$242M$221M$198M
Operating Margin %11.6%12.1%-3.4%0.4%8.8%10.6%5.7%9.7%12.2%13.9%18.0%20.1%21.0%21.0%21.4%22.4%22.3%22.4%22.7%24.1%24.2%
Net Income$175M$165M($99M)($60M)$66M$131M($796M)($1.5B)$269M$320M$325M$336M$317M$281M$241M$218M$203M$176M$169M$143M$124M
Net Margin %9.0%8.6%-4.9%-3.0%3.4%6.9%-45.9%-84.2%7.4%9.3%10.2%12.1%13.0%13.0%13.3%13.7%14.5%13.7%15.8%15.6%15.2%
EBITDA$267M$274M($28M)$30M$157M$236M$146M$204M$528M$588M$661M$622M$559M$492M$422M$382M$336M$307M$258M$225M$208M
Earnings Per Share (EPS)$2.08$1.94$-1.19$-0.73$0.79$1.52$-9.31$-17.78$2.93$3.42$3.47$3.58$3.18$2.77$2.41$2.23$2.13$1.89$1.79$1.43$1.26
Shares Outstanding (M)81M85M83M82M84M86M86M84M92M94M94M94M100M101M100M98M95M93M94M100M99M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$488M$476M$494M$493M$469M$458M$502M$511M
Gross Profit$132M$113M$120M$140M$125M$103M$129M$117M
Gross Margin %27.2%23.7%24.4%28.5%26.6%22.4%25.6%22.9%
Operating Income (EBIT)$57M$47M$55M$68M$60M$32M$39M$34M
Operating Margin %11.7%9.8%11.1%13.8%12.8%7.0%7.8%6.6%
Net Income$40M$30M$34M$72M$39M$21M$30M$19M
Net Margin %8.2%6.2%6.8%14.5%8.4%4.5%6.1%3.8%
EBITDA$57M$53M$60M$96M$69M$43M$50M$42M
Earnings Per Share (EPS)$0.49$0.36$0.40$0.84$0.45$0.24$0.35$0.23
Shares Outstanding (M)81M83M84M86M87M86M86M85M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MD Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$247M$271M$207M$137M$167M$77M$205M$347M$290M$511M$444M$369M$423M$405M$326M$271M$241M$241M$181M$189M$177M
Capital Expenditures (CapEx)$18M$18M$22M$33M$30M$32M$29M$32M$49M$49M$39M$27M$18M$16M$14M$31M$12M$15M$16M$9M$13M
Free Cash Flow (FCF)$229M$253M$185M$104M$137M$44M$176M$315M$241M$462M$405M$342M$405M$390M$311M$240M$228M$226M$166M$180M$164M
FCF Margin %11.7%13.2%9.2%5.2%7.0%2.3%10.1%17.7%6.6%13.4%12.7%12.3%16.6%18.1%17.1%15.1%16.3%17.6%15.5%19.6%20.1%
Dividends Paid$470M$526M$1.7B$2.2B$2.8B$1.9B$2.9B$1.8B$912M$0M$0M$0M$450M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MD Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$125M($130M)$114M$137M$137M($117M)$133M$92M
Capital Expenditures (CapEx)$1M$6M$5M$5M$5M$3M$3M$6M
Free Cash Flow (FCF)$124M($136M)$109M$132M$133M($121M)$130M$86M
FCF Margin %25.4%-28.5%22.0%26.8%28.3%-26.4%25.8%16.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MD Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$2.1B$2.2B$2.2B$2.2B$2.3B$2.7B$3.3B$4.1B$5.9B$5.9B$5.3B$4.5B$3.6B$3.0B$2.8B$2.3B$2.0B$1.7B$1.5B$1.3B$1.1B
Cash & Cash Equivalents$289M$375M$230M$73M$10M$387M$1.1B$108M$37M$60M$56M$52M$48M$31M$21M$19M$26M$27M$14M$103M$70M
Total Liabilities$1.2B$1.4B$1.4B$1.4B$1.5B$1.8B$2.6B$2.6B$2.8B$2.8B$2.6B$2.1B$1.3B$706M$715M$542M$590M$499M$532M$344M$269M
Total Debt (Short + Long-Term)$596M$607M$627M$648M$673M$1.0B$1.8B$1.7B$2.0B$1.9B$1.7B$1.3B$379M$27M$144M$58M$293M$51M$140M$1M$1M
Total Shareholders' Equity$881M$866M$765M$849M$892M$896M$747M$1.5B$3.1B$3.1B$2.8B$2.4B$2.3B$2.3B$2.0B$1.7B$1.4B$1.2B$965M$959M$866M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MD viewer.

Other Companies in MEDICAL CARE FACILITIES

← MCYAll “M” companiesMD4C →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.